drug · small molecule
patient view →delgocitinib
Marketedupdated 2mo agoby Leo Pharma AS🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 4 investigational indications.
targets
Janus Kinase (JAK)
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that